Chrong-Shiong Hwang

Targeting androgen receptor and the variants by an orally bioavailable Proteolysis Targeting Chimeras compound in castration resistant prostate cancer

Chiu-Lien Hung, Hao-Hsuan Liu, Chih‐Wei Fu et al. · EBioMedicine · 2023 · 34 citations · Full text

Medicine, Oncology, Pharmacology +13

Synthesis and structure–activity relationship of 6-arylureido-3-pyrrol-2-ylmethylideneindolin-2-one derivatives as potent receptor tyrosine kinase inhibitors

Rahul R. Khanwelkar, Grace Shiahuy Chen, Hsiao-Chun Wang et al. · Bioorganic & Medicinal Chemistry · 2010 · 28 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia

Cherng-Ru Hsu, Yi‐Hsun Chen, Chih-Peng Liu et al. · Investigative Ophthalmology & Visual Science · 2019 · 26 citations · Full text

Medicine, Ophthalmology, Pharmacology +17

Inhibition of Retinal Ganglion Cell Loss By a Novel ROCK Inhibitor (E212) in Ischemic Optic Nerve Injury Via Antioxidative and Anti-Inflammatory Actions

Yao‐Tseng Wen, Ching-Wen Huang, Chih-Peng Liu et al. · Investigative Ophthalmology & Visual Science · 2021 · 19 citations · Full text

Medicine, Neurobiology, Neuroscience +17

Synthesis of 1-substituted 3-pyridinylmethylidenylindolin-2-ones and 1-substituted 3-quinolinylmethylidenylindolin-2-ones as the enhancers of ATRA-induced differentiation in HL-60 cells

Chi-Ying Hung, Mei‐Hua Hsu, Li‐Jiau Huang et al. · Bioorganic & Medicinal Chemistry · 2008 · 14 citations

Life Sciences, Molecular Biology, Pharmacology +5